Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer

Fig. 5

Functional enrichment analysis between high-risk group and low-risk group. A Hallmark gene sets were quantified by “GSVA” and compared between high-risk group and low-risk group; B GSEA to explore the difference of pathway between high-risk group and low-risk group; C Cancer-related pathways presented significant survival difference in CESC

Back to article page